Showing results (261-270 of 286) with videos related to
Sort By:
Pageof 29
Diabetes, Obesity & Metabolism|May 30, 2009
Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulinK Rave, E Potocka, L Heinemann, et al.European Journal of Clinical Nutrition|June 1, 1989
Results from a comparative dietary assessment in Europe: II. Feasibility of pooling individual-based dietary data between countriesJ Wahrendorf, H Boeing, L Heinemann, et al.Diabetes, Obesity & Metabolism|June 27, 2007
Insulin glulisine: a faster onset of action compared with insulin lisproT Heise, L Nosek, H Spitzer, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1996
Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulinL Heinemann, T Heise, L C Wahl, et al.Diabetes, Obesity & Metabolism|March 22, 2008
Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjectsR H A Becker, A D Frick, L Teichert, et al.Diabetologia|July 1, 1994
Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjectsF J Ampudia-Blasco, L Heinemann, R Bender, et al.Clinical Chemistry and Laboratory Medicine|March 1, 2020
Challenges of LC-MS/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidatesMitja L Heinemann, Louis Elsing, Thorsten Kaiser, et al.Diabetes Care|May 20, 1998
Time-action profiles of novel premixed preparations of insulin lispro and NPL insulinT Heise, C Weyer, A Serwas, et al.Oncotarget|February 4, 2016
JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cellsAlejandro Recio-Boiles, Matthias Ilmer, P Robyn Rhea, et al.Journal of Inflammation (London, England)|February 11, 2025
Auto-antibodies against carbonyl-modified vimentin in COPD: potential role as a biomarkerL Heinemann, I Adcock, K F Chung, et al.Pageof 29